Short answer
MBX Biosciences, Inc. (MBX) filed an 8-K current report with the SEC on June 5, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders). 2026 annual stockholder meeting held June 4, 2026.
MBX Biosciences, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- 2026 annual stockholder meeting held June 4, 2026
- Section excerpt ends before describing director or officer changes
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Stockholders elected Class II directors Patrick J. Heron and Edward T. Mathers through the 2029 annual meeting
- Heron received 35,007,623 votes for and 4,579,129 withheld
- Mathers received 31,983,223 votes for and 7,603,529 withheld
- Ernst & Young LLP ratified as independent auditor for fiscal year ending December 31, 2026
- Auditor ratification passed with 43,713,693 votes for versus 1,946 against and 1,946 abstentions
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other MBX Biosciences, Inc. 8-K filings
Get the next MBX 8-K as it lands
Follow MBX for push alerts, or ask the research agent what this filing means.